尿路癌中的免疫检查点抑制剂:患者选择,毒性管理,反应评估和治疗顺序的实际框架
Abdul Rahman Al Armashi1, Jenny Gong1, Pedro Barata1
1Seidman Cancer Center, University Hospitals, Cleveland, OH , USA.
Expert review of anticancer therapy
|February 9, 2026
概括
尿路癌的免疫检查点抑制剂面临实施挑战,生物标志物有限,以及毒性问题. 优化免疫疗法需要更好地管理不良事件,评估反应和公平获得护理.
科学领域:
- 在瘤学瘤学.
- 免疫治疗是一种免疫疗法.
- 尿路细胞癌是什么意思
背景情况:
- 免疫检查点抑制剂 (ICI) 对泌尿腺癌至关重要,但存在重大实施挑战.
- 预测生物标志物的有限实用性,如编程死亡配体1 (PD-L1) 和瘤突变负担 (TMB),使治疗选择复杂化.
- 由于毒性和评估临床反应的困难导致治疗中止仍然存在问题.
研究的目的:
- 为了提供一个全面的概述当前的挑战和未来的方向在管理尿癌与ICIs.
- 整合来自临床试验,系统审查和2016年至2025年卫生系统评估的证据.
- 提供专家意见,以优化免疫疗法护理的提供和患者的结果.
主要方法:
- 临床试验,卫生系统评估和指导方针 (2016-2025) 的系统审查.
- 预测生物标志物 (PD-L1,TMB) 和响应标准 (iRECIST) 的局限性分析.
- 对毒性管理,伪进展,超进展和ICI后测序策略的评估.
主要成果:
- 确定了PD-L1表达和TMB实用性的限制.
- 管理免疫相关不良事件和解释临床反应 (伪进展,超进展) 的详细挑战.
- 强调需要改进交付模型,包括导航,患者报告的结果和远程医疗.
结论:
- 优化免疫疗法需要强大的框架来管理不良事件,标准化反应评估,并确保公平的获取.
- 像ctDNA和人工智能辅助放射学这样的新兴技术显示出希望,但需要进一步验证.
- 系统性改进对于使用ICI有效且易于获得的尿路癌治疗至关重要.
相关概念视频
Humoral Immune Responses
84.1K
Overview
84.1K
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
619
Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
619
Cell-mediated Immune Responses
84.2K
Overview
84.2K
Cells of the Adaptive Immune Response
9.0K
The T and B lymphocytes of the adaptive immune system develop from common lymphoid progenitor cells in the bone marrow. These progenitors give rise to precursors that eventually develop into both T and B lymphocytes. As these precursors mature, they gain the ability to detect and respond to foreign antigens in the body, a process known as immunocompetence. Additionally, these precursors acquire self-tolerance, a process that ensures they do not react to self-antigens. This intricate system...
9.0K
Immune Response Against Viral Pathogens
2.1K
The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
2.1K
Cells of the Innate Immune Response
9.4K
The innate immune response is an immediate and non-specific response against pathogens, acting swiftly to prevent the spread of infections. The primary cells involved in this response are phagocytes and natural killer (NK) cells.
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...
9.4K


